Breaking News

BIA Separations and Biomay collaborate on production and purification of large DNA plasmids

The collaboration enables high yield, high purity supercoiled plasmid DNA manufacture for therapeutic application

NHSA signs health and MedTech MOU with Israel

Northern Health Science Alliance (NHSA) has signed an MOU with the UK Israel Tech Hub (UKITH) to bring Israeli health ...

GE increases cell culture media production capacity tenfold

Newly built manufacturing suite in Austria and expanded capacity at the Logan site in the US to support biopharma ...

Meet… Harald Castler

As President of Getinge Life Science and former Chairman of Halmstad University, Harald sees his role as facilitating ...

Life Sciences sector responds to report on the impact of Brexit

The Business, Energy and Indsutrial Strategy (BEIS) Committee report calls on the Government to secure a post-Brexit ...

New therapeutic target for rheumatoid arthritis

University of Birmingham Enterprise announces the formation of a new spinout company, Viatem Ltd, to develop and ...

Invisible benefits

SCHOTT enhances its iQ platform with the introduction of the new syriQ BioPure glass syringe for sensitive drugs

New strategic alliance taps into controlled environment market

Nine companies have joined forces to launch Professional Partners for Controlled Environment to create a platform for ...

BC Platforms partners with Google Cloud

The partnership will aim to deliver a highly scalable integrated genomic and clinical data solution to hospitals and ...

On the home stretch to the serialisation deadline

With serialisation legislation looming, Manufacturing Chemist spoke to David Carpentier, founder and CTO at Adents, to ...

Accelerating drug discovery

Angharad Baldwin of Manufacturing Chemist speaks to Dr Trevor Perrior, CSO of Domainex, about the development of a new ...

More than simply fizzy

Technologies to tablet effervescent products

Emergex receives Innovate UK Grant to progress flu vaccine

The biotechnology company, which is aiming to find a new approach to vaccine development, has received a grant to ...

Risankizumab approval could strengthen AbbVie's market position

According to GlobalData, if approved, risankizumab would further strengthen AbbVie’s position in the psoriasis market